smith & nephew medical limited
smith & nephew medical limited Company Information
Company Number
00605496
Next Accounts
Sep 2025
Shareholders
smith & nephew investment holdings ltd
smith & nephew nominee services ltd
Group Structure
View All
Industry
Non-trading company
Registered Address
101 hessle road, hull, england, HU3 2BN
Website
www.smith-nephew.comsmith & nephew medical limited Estimated Valuation
Pomanda estimates the enterprise value of SMITH & NEPHEW MEDICAL LIMITED at £0 based on a Turnover of £0 and 0.54x industry multiple (adjusted for size and gross margin).
smith & nephew medical limited Estimated Valuation
Pomanda estimates the enterprise value of SMITH & NEPHEW MEDICAL LIMITED at £0 based on an EBITDA of £0 and a 4.24x industry multiple (adjusted for size and gross margin).
smith & nephew medical limited Estimated Valuation
Pomanda estimates the enterprise value of SMITH & NEPHEW MEDICAL LIMITED at £130 based on Net Assets of £100 and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Smith & Nephew Medical Limited Overview
Smith & Nephew Medical Limited is a live company located in england, HU3 2BN with a Companies House number of 00605496. It operates in the non-trading company sector, SIC Code 74990. Founded in June 1958, it's largest shareholder is smith & nephew investment holdings ltd with a 99% stake. Smith & Nephew Medical Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Smith & Nephew Medical Limited Health Check
There is insufficient data available to calculate a health check for Smith & Nephew Medical Limited. Company Health Check FAQs
0 Strong
0 Regular
3 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Smith & Nephew Medical Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Smith & Nephew Medical Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Smith & Nephew Medical Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Smith & Nephew Medical Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (41)
- Smith & Nephew Medical Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Smith & Nephew Medical Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Smith & Nephew Medical Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Smith & Nephew Medical Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Smith & Nephew Medical Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Smith & Nephew Medical Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (33 weeks)
- - Smith & Nephew Medical Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 100%, this is a higher level of debt than the average (47.9%)
- - Smith & Nephew Medical Limited
- - Industry AVG
SMITH & NEPHEW MEDICAL LIMITED financials
Smith & Nephew Medical Limited's latest turnover from December 2023 is 0 and the company has net assets of £100. According to their latest financial statements, we estimate that Smith & Nephew Medical Limited has 1 employee and maintains cash reserves of £43.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | |||||||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 1,118,168 | 1,716,973 | 865,202 | 717,519 | 960,256 | 1,513,298 | 1,157,419 | 1,634,660 | |||||||
| Group Debtors | 111,050,009 | 100,820,352 | 77,396,212 | 85,522,418 | 84,843,375 | 84,619,262 | 87,366,659 | 84,415,247 | |||||||
| Misc Debtors | 2,810,338 | 4,422,312 | 2,680,942 | 986,726 | 1,313,185 | 6,531,461 | 6,105,563 | 3,646,334 | |||||||
| Cash | 43,102 | 3,399,246 | 153,559 | 74,508 | 73,087 | 2,077 | 44,934 | 632,279 | |||||||
| misc current assets | |||||||||||||||
| total current assets | 115,021,617 | 110,358,883 | 81,095,915 | 87,301,171 | 87,189,903 | 92,666,098 | 94,674,575 | 90,328,520 | |||||||
| total assets | 115,021,617 | 110,358,883 | 81,095,915 | 87,301,171 | 87,189,903 | 92,666,098 | 94,674,575 | 90,328,520 | |||||||
| Bank overdraft | 66,488 | 306,236 | |||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 4,290,057 | 5,144,180 | 4,359,385 | 2,203,874 | 2,389,272 | 4,809,795 | 3,951,318 | 3,341,057 | |||||||
| Group/Directors Accounts | 102,787,299 | 98,500,780 | 74,279,678 | 83,314,056 | 82,653,464 | 82,256,294 | 87,586,013 | 83,351,337 | |||||||
| other short term finances | 75,576 | 54,314 | |||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 7,877,673 | 6,407,587 | 2,381,176 | 1,728,827 | 2,147,067 | 5,599,909 | 3,137,144 | 3,636,026 | |||||||
| total current liabilities | 115,021,517 | 110,358,783 | 81,095,815 | 87,301,071 | 87,189,803 | 92,665,998 | 94,674,475 | 90,328,420 | |||||||
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 115,021,517 | 110,358,783 | 81,095,815 | 87,301,071 | 87,189,803 | 92,665,998 | 94,674,475 | 90,328,420 | |||||||
| net assets | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||||
| total shareholders funds | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 8,018,878 | 26,017,281 | -6,284,307 | 109,847 | -5,547,205 | -1,965,620 | 4,933,400 | 89,696,241 | |||||||
| Creditors | -854,123 | 784,795 | 2,155,511 | -185,398 | -2,420,523 | 858,477 | 610,261 | 3,341,057 | |||||||
| Accruals and Deferred Income | 1,470,086 | 4,026,411 | 652,349 | -418,240 | -3,452,842 | 2,462,765 | -498,882 | 3,636,026 | |||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | -7,402,915 | -21,206,075 | 9,092,167 | -713,485 | -326,160 | 5,286,862 | -4,822,021 | -82,719,158 | |||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 4,286,519 | 24,221,102 | -9,034,378 | 660,592 | 397,170 | -5,329,719 | 4,234,676 | 83,351,337 | |||||||
| Other Short Term Loans | -75,576 | 21,262 | 54,314 | ||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | 4,286,519 | 24,145,526 | -9,013,116 | 714,906 | 397,170 | -5,329,719 | 4,234,676 | 83,351,437 | |||||||
| cash and cash equivalents | |||||||||||||||
| cash | -3,356,144 | 3,245,687 | 79,051 | 1,421 | 71,010 | -42,857 | -587,345 | 632,279 | |||||||
| overdraft | -239,748 | 306,236 | |||||||||||||
| change in cash | -3,116,396 | 2,939,451 | 79,051 | 1,421 | 71,010 | -42,857 | -587,345 | 632,279 |
smith & nephew medical limited Credit Report and Business Information
Smith & Nephew Medical Limited Competitor Analysis
Perform a competitor analysis for smith & nephew medical limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mature companies, companies in HU3 area or any other competitors across 12 key performance metrics.
smith & nephew medical limited Ownership
SMITH & NEPHEW MEDICAL LIMITED group structure
Smith & Nephew Medical Limited has no subsidiary companies.
Ultimate parent company
2 parents
SMITH & NEPHEW MEDICAL LIMITED
00605496
smith & nephew medical limited directors
Smith & Nephew Medical Limited currently has 6 directors. The longest serving directors include Mr John MacKinnon (Jan 2016) and Mrs Sarah Carne (Apr 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr John MacKinnon | United Kingdom | 59 years | Jan 2016 | - | Director |
| Mrs Sarah Carne | United Kingdom | 55 years | Apr 2022 | - | Director |
| Mr Jon Klemp | United Kingdom | 49 years | May 2022 | - | Director |
| Mr Jon Klemp | United Kingdom | 49 years | May 2022 | - | Director |
| Mr Jon Klemp | United Kingdom | 49 years | May 2022 | - | Director |
| Ms Helen Barraclough | England | 46 years | Jun 2024 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
100
0%
total assets
115m
+0.04%
cash
43.1k
-0.99%
net assets
Total assets minus all liabilities
Similar Companies
smith & nephew medical limited company details
company number
00605496
Type
Private limited with Share Capital
industry
74990 - Non-trading company
incorporation date
June 1958
age
67
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
smith & nephew-southalls limited (December 1981)
accountant
-
auditor
KPMG LLP
address
101 hessle road, hull, england, HU3 2BN
Bank
-
Legal Advisor
-
smith & nephew medical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to smith & nephew medical limited.
smith & nephew medical limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SMITH & NEPHEW MEDICAL LIMITED. This can take several minutes, an email will notify you when this has completed.
smith & nephew medical limited Companies House Filings - See Documents
| date | description | view/download |
|---|
